THALIDOMIDE APPROVAL RECOMMENDATION WOULD OVERRULE FDA PRIMARY REVIEWERS, DIVISION DIRECTOR; REVIEW WOULD BE SYMBOL OF NEW FDA THEMES OF PATIENT ACCESS